Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00197262
Status:
COMPLETED
Last Update Posted:
2017-01-19
First Post:
2005-09-15
Brief Title:
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis SAR
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Randomized Single-Blind Placebo-Controlled Parallel-Group Multicenter Study to Evaluate the Efficacy of Once-Daily Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure The focus of this study seasonal allergic rhinitis SAR is one type of allergic rhinitis that is triggered by the pollen from trees grasses and weeds Commonly referred to as hay fever it is characterized by sneezing nasal congestion and pruritus rhinorrhea and pruritic watery red eyes The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily QD aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects 12 years of age and older with seasonal allergic rhinitis SAR caused by ragweed pollen
Detailed Description:
A Randomized Double-Blind Placebo-Controlled Parallel-Group Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 2 Weeks in Adult and Adolescent Subjects 12 years of age and older with Seasonal Allergic Rhinitis SAR
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None